CN209790495U - Pulsating catheter device for assisting left ventricle function - Google Patents

Pulsating catheter device for assisting left ventricle function Download PDF

Info

Publication number
CN209790495U
CN209790495U CN201821885671.0U CN201821885671U CN209790495U CN 209790495 U CN209790495 U CN 209790495U CN 201821885671 U CN201821885671 U CN 201821885671U CN 209790495 U CN209790495 U CN 209790495U
Authority
CN
China
Prior art keywords
balloon
control module
valve
aorta
support
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201821885671.0U
Other languages
Chinese (zh)
Inventor
解启莲
贺照明
刘晓程
李国荣
马祖长
彭虎
陈远龙
余洪龙
解尧
李剑
陈宏凯
徐小菊
宋泽阳
王昆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui Tongling Bionic Technology Co Ltd
Original Assignee
Anhui Tongling Bionic Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui Tongling Bionic Technology Co Ltd filed Critical Anhui Tongling Bionic Technology Co Ltd
Priority to CN201821885671.0U priority Critical patent/CN209790495U/en
Application granted granted Critical
Publication of CN209790495U publication Critical patent/CN209790495U/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The utility model discloses a pulsation formula pipe device of supplementary left ventricle function, including executive component and control module, the executive component includes sacculus, support and the artificial valve through can filling the gassing, the support is located the one end of sacculus, is equipped with the artificial valve who is used for the valve effect in the support, the sacculus is via the external ventricular assist catheter pump of air duct, control module is located the ventricular assist catheter pump, the executive component promote the blood of left ventricle to the aorta via control module control and with patient's heart beat characteristic adaptation realization. The utility model provides a pair of synchronous heart auxiliary device of wicresoft's pipe formula can realize promoting the blood in patient's left atrium to the aorta, to patient's cardiovascular surgery postoperative recovery, heart transplant transition or replace, the recovery of myocardium function and even the permanent treatment of heart failure all have apparent effect, and the while cost is with low costs, and simple structure is compact, is convenient for popularize and promote.

Description

Pulsating catheter device for assisting left ventricle function
the technical field is as follows:
the utility model relates to a heart assisted cycle field specifically relates to a pulsation formula pipe device of supplementary left ventricle function.
Background art:
Heart failure is a disease seriously threatening human life, about 1/5 heart disease patients can finally develop into heart failure every year all over the world, the heart failure incidence rate in China reaches 0.9 percent and the death rate in 5 years exceeds 60 percent at present. When the traditional medical treatment has certain limitations and can not achieve satisfactory curative effect, and the heart transplantation is difficult due to donor deficiency, postoperative rejection and the like, researchers propose a method for helping the heart to recover by using a mechanical device and develop a ventricular assist device. Since the clinical application in the 60's last century, through years of research and clinical application, the application of ventricular assist devices has expanded from resuscitation after cardiovascular surgery, transition or replacement of heart transplantation, to restoration of myocardial function and even permanent treatment of heart failure. The ventricular assist device can be used as a bridge for transition before heart transplantation and also used as a flat boat leading to myocardial recovery to improve the life quality of heart failure patients and be used for treating the heart failure patients.
the ventricular assist device is the most effective treatment method for various end-stage heart failure recognized all over the world. The development of the first generation pneumatic blood pump and the second generation axial flow blood pump in the 60 th generation of the world to the third generation suspension blood pump of today goes through the difficult research course of several scientists. The study on the ventricular assist device is carried out in the beginning of the last 80 th century in China, although the study is made by several generations of people, the study has a larger gap compared with the study made by foreign countries, and no commercialized domestic heart assist device is provided for clinical application so far. Although commercial ventricular assist devices exist abroad, the price of one device is as high as 50-100 ten thousand yuan RMB, but the price of one device is high. Therefore, it is urgent to develop a new home-made ventricular assist device with excellent performance and low cost. The first implantable ventricular assist device and the third ventricular assist device in China are successfully developed by the cooperation of Chinese engineering teams and medical teams, the longest survival record of the domestic implanted third ventricular assist device is created by animal experiments, and the development of the third ventricular assist device in China makes a major breakthrough.
however, the domestic third generation ventricular assist device is implantable and non-pulsatile, which not only needs to be implanted by a surgical operation to cause a large wound, but also does not accord with the physiological characteristics of pulsatile self of a human body. The device is implanted in a minimally invasive mode, the pulsating characteristic of the heart is continuously kept, and the direction of blood flow emitted into the aorta is consistent with the direction of blood flow emitted by the heart, so that the ventricular assist efficiency of the device is further improved.
SUMMERY OF THE UTILITY MODEL
The utility model overcomes the defects of the prior art and provides a pulsating catheter device for assisting the function of the left ventricle.
the utility model discloses the technical problem that will solve adopts following technical scheme to realize:
A pulsating catheter device for assisting left ventricle function is characterized by comprising an executing part and a control module, wherein the executing part comprises a balloon capable of being inflated and deflated, a support and a prosthetic valve, the support is located at one end of the balloon, the prosthetic valve used for functioning as a valve is arranged in the support, the balloon is externally connected with a ventricular assist catheter pump through a hose, the control module is located in the ventricular assist catheter pump, and the executing part is controlled by the control module and matched with the heart beating characteristic of a patient to realize that blood in the left ventricle is lifted to the aorta.
Further technology: the saccule and the bracket at the rear end of the saccule are positioned in a descending aorta of an aorta, and the bracket at the front end of the saccule is positioned in an ascending aorta of the aorta.
The utility model provides a supplementary left ventricle function's pulsation formula pipe device which characterized in that, includes executive component and control module, the executive component includes sacculus, support and the artificial valve through can filling gassing, the rear end of sacculus is equipped with the support, is equipped with the artificial valve that is used for playing the valve effect in the support, the front end of sacculus is equipped with second sacculus, links to each other through the air duct between two sacculus, the sacculus is via the external ventricular assist catheter pump of hose, control module is located ventricular assist catheter pump, the executive component control and with patient's heart beat characteristic adaptation realization promote the blood of left ventricle to the aorta via control module.
further technology: the balloon and the bracket at the rear end of the balloon are positioned in the descending aorta of the aorta, and the second balloon at the front end of the balloon is positioned in the ascending aorta of the aorta.
further technology: the air duct is inserted in the hose, the air duct penetrates through the balloon, a plurality of micro holes are formed in the wall of the air duct in the balloon, and helium enters and exits the balloon through the micro holes of the air duct to complete the inflation and deflation process of the balloon.
Further technology: the stent is a nickel-titanium alloy stent formed by nickel-titanium alloy wires.
further technology: the inside and the outside of the bracket are provided with envelopes, the envelopes are made of biological materials, and the envelopes cover the inside and the outside of the bracket.
further technology: the artificial valve is a tri-leaflet valve, namely the valve has three total valve leaflets, the valve leaflets are sewed on the inner envelope, and the three valve leaflets are opened or closed along with the flow of blood.
A method of using a pulsatile catheter device to assist left ventricular function comprising the steps of:
S1: auxiliary work such as hemostasis and disinfection is firstly carried out, the executive component is stretched into a slender tube shape and is accessed into the aorta of a patient by adopting a micro-wound mode;
S2: the executing part placed in the left ventricular outflow tract is supported on the inner wall of the blood vessel through a bracket;
S3: the adjusting control module controls the ventricular assist catheter pump to be matched with the heart pulsation characteristics of the patient, the ventricular assist catheter pump is connected with an electrocardiograph through an AP interface, and the physical state of the patient is observed through the electrocardiograph;
S4: when the patient is in good condition and the pulsating catheter device for assisting the left ventricle function needs to be removed, the executive component is pulled into a slender tube shape again to be taken out.
The working process is as follows: at the end of diastole and the early stage of ventricular contraction, helium in the saccule is quickly emptied, the saccule contracts quickly, and the artificial valve is also closed quickly at the same time, so that the pressure in the aorta is suddenly reduced;
Then, the systolic phase of the heart begins, the aortic valve is opened, the blood in the left ventricle is sprayed into the aorta, and the artificial valve is opened until the diastolic phase comes;
Then the diastole begins, the aortic valve closes, the balloon inflates rapidly, the balloon swells, and blood is expelled to the two ends of the aorta.
these three processes cycle back and forth.
Compared with the prior art, the beneficial effects of the utility model are that:
1. the minimally invasive catheter type synchronous heart auxiliary device provided by the utility model can lift the blood in the left atrium of a patient to the aorta, has obvious effect on the treatment of various severe heart failures, and has the advantages of low cost, simple and compact structure, and convenient popularization;
2. Compared with a mechanical device, on one hand, the heart assist device has high matching with an inner cavity, simple structure, convenience for flexible power transmission, easiness for realizing a valve control function, low manufacturing cost and capability of reducing the production cost of the heart assist device, and more importantly, the air bag has small damage to blood cells and cannot cause secondary damage to patients;
3. The reticular stent and the cavity wall made of the memory alloy have structural variability, and minimally invasive treatment is realized only by pulling the executive component into a slender tube, so that the injury to a patient is small on the premise of realizing the function of the device;
4. When the patient is treated, the blood in the left ventricle of the patient is directly lifted to the aorta, the air pump is controlled by the control module and is matched with the heart beating characteristic of the patient, the process is not reversed, and the device has the advantages of high efficiency and good treatment effect.
5. A relatively closed space is formed between the artificial valve and the native aorta of the human body, the bracket plays a role in supporting the blood vessel to prevent collapse, the balloon is deflated in the relatively closed space, the increase of negative pressure is obviously increased, and the heart is effectively reduced to meet the requirement.
6. The utility model discloses the gasbag is located arterial descending aorta, wholly is vertical direction, does not bend, and the elasticity that every position of gasbag lateral wall was received is the same, has avoided the branch pipe mouth of pipe of supply cerebral vessel simultaneously, does not influence the blood vessel of supply cerebral.
7. this application is divided into two with the gasbag, all is equipped with one in ascending aorta and the descending aorta, and both all present vertical state, abandon on the ascending aorta and use the support, take valve cooperation gasbag wage certainly, and it is the same through the air duct in the middle of two gasbags, do not also influence the blood vessel of supply brain, it is nearer to be located the left ventricle, has further promoted ventricle auxiliary efficiency.
Drawings
Fig. 1 is a schematic structural view of the whole of embodiment 1 of the present invention;
fig. 2 is a sectional view of the integral body of embodiment 2 of the present invention;
FIG. 3 is a schematic view of the structure of the air duct inside the air bag of the present invention;
FIG. 4 is a schematic view of the bracket structure of the present invention;
FIG. 5 is a schematic view of the structure of the artificial valve of the present invention;
In the figure: 1. a balloon; 2. a support; 3. a prosthetic valve; 4. an air duct; 5. a ventricular assist catheter pump; 6. a micro-hole; 7. a rigid circular conduit; 8. enveloping; 9. and (7) valve blades.
Detailed Description
In order to solve the inside structure that does not design the support crane span structure main part of current polymer lining steel type ladder crane span structure and the general design of crossbeam of ladder crane span structure be fixed problem, the embodiment of the utility model provides a polymer lining steel type ladder crane span structure. The technical solutions in the embodiments of the present invention will be described clearly and completely with reference to the accompanying drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only some embodiments of the present invention, not all embodiments. Based on the embodiments in the present invention, all other embodiments obtained by a person skilled in the art without creative work belong to the protection scope of the present invention.
Example 1: FIGS. 1, 3 to 5
The utility model provides a pulsation formula catheter device of supplementary left ventricle function, includes executive component and control module, the executive component includes sacculus 1, support 2 and artificial valve 3 through can filling the gassing, the rear end of sacculus is equipped with the support, is equipped with the artificial valve that is used for playing the valve effect in the support, the sacculus is via the external ventricular assist catheter pump 5 of hose 4, control module is located the ventricular assist catheter pump, the executive component realize lifting the blood of left ventricle to the aorta with patient's heart beat characteristic adaptation via control module control.
the balloon and the stent at the rear end of the balloon are positioned in the descending aorta of the aorta, and the stent at the front end of the balloon is positioned in the ascending aorta of the aorta.
an air duct 7 is inserted in the hose in a penetrating manner, the air duct penetrates through the balloon, a plurality of micro holes are formed in the wall of the air duct in the balloon, and helium enters and exits the balloon through the micro holes 6 of the air duct to complete the inflation and deflation process of the balloon.
The stent is a nickel-titanium alloy stent formed by nickel-titanium alloy wires.
The inside and the outside of the bracket are provided with envelopes 8, the envelopes are made of biological materials, and the envelopes cover the inside and the outside of the bracket.
The artificial valve is a tri-leaflet valve, i.e. the valve has three total leaflets 9, which are sutured on the inner envelope and open or close with the flow of blood.
Example 2: FIGS. 2 to 5
The utility model provides a supplementary pulsation formula catheter device of left ventricle function, includes executive component and control module, the executive component includes sacculus 1, support 2 and artificial valve 3 through can filling the gassing, the both ends are equipped with the support respectively around the sacculus, are equipped with the artificial valve that is used for playing the valve effect in the support, the sacculus is via the external ventricular assist catheter pump 5 of hose 4, control module is located the ventricular assist catheter pump, the executive component realize lifting the blood of left ventricle to the aorta with patient's heart beat characteristic adaptation via control module control.
The balloon and the stent at the rear end of the balloon are positioned in the descending aorta of the aorta, and the second balloon at the front end of the balloon is positioned in the ascending aorta of the aorta.
An air duct 7 is inserted in the hose in a penetrating way, the air duct penetrates through the saccule, the wall of the air duct in the saccule is provided with a plurality of micro holes, and helium enters and exits the saccule through the micro holes 6 of the air duct to complete the inflation and deflation process of the saccule.
the stent is a nickel-titanium alloy stent formed by nickel-titanium alloy wires.
The inside and the outside of the bracket are provided with envelopes 8, the envelopes are made of biological materials, and the envelopes cover the inside and the outside of the bracket.
The artificial valve is a tri-leaflet valve, i.e. the valve has three total leaflets 9, which are sutured on the inner envelope and open or close with the flow of blood.
a method of using a pulsatile catheter device to assist left ventricular function comprising the steps of:
S1: auxiliary work such as hemostasis and disinfection is firstly carried out, the executive component is stretched into a slender tube shape and is accessed into the aorta of a patient by adopting a micro-wound mode;
s2: the executing part placed in the left ventricular outflow tract is supported on the inner wall of the blood vessel through a bracket;
S3: the adjusting control module controls the ventricular assist catheter pump to be matched with the heart pulsation characteristics of the patient, the ventricular assist catheter pump is connected with an electrocardiograph through an AP interface, and the physical state of the patient is observed through the electrocardiograph;
S4: when the patient is in good condition and the pulsating catheter device for assisting the left ventricle function needs to be removed, the executive component is pulled into a slender tube shape again to be taken out.
The working process is as follows: at the end of diastole and the early stage of ventricular contraction, helium in the saccule is quickly emptied, the saccule contracts quickly, and the artificial valve is also closed quickly at the same time, so that the pressure in the aorta is suddenly reduced;
then, the systolic phase of the heart begins, the aortic valve is opened, blood in the left ventricle is sprayed into the aorta, and then the left ventricle is manually opened until the diastolic phase comes;
Then the diastole begins, the aortic valve closes, the balloon inflates rapidly, the balloon swells, and blood is expelled to the two ends of the aorta.
These three processes cycle back and forth.
in the description of the present invention, it should be noted that the terms "vertical", "upper", "lower", "horizontal", and the like indicate orientations or positional relationships based on the orientations or positional relationships shown in the drawings, and are only for convenience of description and simplification of the description, but do not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and thus, should not be construed as limiting the present invention.
In the description of the present invention, it should be further noted that, unless explicitly stated or limited otherwise, the terms "disposed," "mounted," "connected," and "connected" are to be construed broadly and may be, for example, fixedly connected, detachably connected, or integrally connected, mechanically connected, electrically connected, directly connected, connected through an intermediate medium, or connected to the inside of two elements. The specific meaning of the above terms in the present invention can be understood according to specific situations by those skilled in the art.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.

Claims (5)

1. A pulsating catheter device for assisting left ventricle function is characterized by comprising an executing part and a control module, wherein the executing part comprises a balloon capable of being inflated and deflated, a support and a prosthetic valve, the support is located at one end of the balloon, the prosthetic valve used for functioning as a valve is arranged in the support, the balloon is externally connected with a ventricular assist catheter pump through a hose, the control module is located in the ventricular assist catheter pump, and the executing part is controlled by the control module and matched with the heart beating characteristic of a patient to realize that blood in the left ventricle is lifted to the aorta.
2. a pulsating catheter device as in claim 1, wherein an airway tube is inserted through said flexible tube, said airway tube passing through said balloon, said airway tube having a plurality of micro holes in its wall, and helium gas entering and exiting said balloon through said micro holes of said airway tube to complete the inflation and deflation of said balloon.
3. A pulsatile catheter device to assist left ventricular function as claimed in claim 1, wherein the stent is a nitinol stent formed from nitinol wire.
4. A pulsatile catheter device to assist left ventricular function as claimed in claim 1, wherein the stent has a coating on the inside and outside of the stent, the coating being made of biomaterial, the coating being on the inside and outside of the stent.
5. A pulsatile catheter device to assist left ventricular function as claimed in claim 1, wherein said artificial valve is a tri-leaflet valve having three leaflets in total, sutured to the inner envelope, which open and close with blood flow.
CN201821885671.0U 2018-11-15 2018-11-15 Pulsating catheter device for assisting left ventricle function Active CN209790495U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201821885671.0U CN209790495U (en) 2018-11-15 2018-11-15 Pulsating catheter device for assisting left ventricle function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201821885671.0U CN209790495U (en) 2018-11-15 2018-11-15 Pulsating catheter device for assisting left ventricle function

Publications (1)

Publication Number Publication Date
CN209790495U true CN209790495U (en) 2019-12-17

Family

ID=68816970

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201821885671.0U Active CN209790495U (en) 2018-11-15 2018-11-15 Pulsating catheter device for assisting left ventricle function

Country Status (1)

Country Link
CN (1) CN209790495U (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109395185A (en) * 2018-11-15 2019-03-01 安徽通灵仿生科技有限公司 A kind of pulsation type conduit device assisting left ventricular function
US11368081B2 (en) 2018-01-24 2022-06-21 Kardion Gmbh Magnetic coupling element with a magnetic bearing function
US11754075B2 (en) 2018-07-10 2023-09-12 Kardion Gmbh Impeller for an implantable, vascular support system
US11944805B2 (en) 2020-01-31 2024-04-02 Kardion Gmbh Pump for delivering a fluid and method of manufacturing a pump

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11368081B2 (en) 2018-01-24 2022-06-21 Kardion Gmbh Magnetic coupling element with a magnetic bearing function
US11804767B2 (en) 2018-01-24 2023-10-31 Kardion Gmbh Magnetic coupling element with a magnetic bearing function
US11754075B2 (en) 2018-07-10 2023-09-12 Kardion Gmbh Impeller for an implantable, vascular support system
CN109395185A (en) * 2018-11-15 2019-03-01 安徽通灵仿生科技有限公司 A kind of pulsation type conduit device assisting left ventricular function
US11944805B2 (en) 2020-01-31 2024-04-02 Kardion Gmbh Pump for delivering a fluid and method of manufacturing a pump

Similar Documents

Publication Publication Date Title
CN209790495U (en) Pulsating catheter device for assisting left ventricle function
US6945998B2 (en) Corporal implantation device for assisting blood and heart ventricular circulation
US7357771B2 (en) Heart assist devices, systems and methods
JP5339161B2 (en) Manifold
US20070208210A1 (en) Method and apparatus to unload a failing heart
US9623163B1 (en) Left ventricle heart-assist device
CN202892148U (en) Support valve and conveying device thereof
CN102038979B (en) Heart impulse assisting system
US20090177028A1 (en) Non-blood contact cardiac compression device, for augmentation of cardiac function by timed cyclic tensioning of elastic cords in an epicardial location
US20080207986A1 (en) Heart assist device
JP2013545549A (en) Pneumatic or hydraulic heart assist device
CN212383079U (en) External pressing type heart auxiliary device for ventricles
CN108310497B (en) Minimally invasive catheter type synchronous heart auxiliary device and application method thereof
CN201519326U (en) Cardiac pulsation auxiliary system
CN109395185A (en) A kind of pulsation type conduit device assisting left ventricular function
CN210812926U (en) Sequential balloon counterpulsation type left heart auxiliary device
CN209286295U (en) The synchronous heart-assist device of minimally invasive catheter type
DE19951220A1 (en) Pericardial heart support system in the form of inflatable sac
CN211157660U (en) Refractory heart failure left ventricle function auxiliary device
CN219071821U (en) Left ventricle blood pumping device
CN201040049Y (en) Pulmonary artery bracket with valve
CN110124133B (en) Intractable heart failure left ventricle function auxiliary device
CN216168100U (en) Percutaneous implanted diastole auxiliary system
CN109316641A (en) A kind of artificial heart device
CN216877594U (en) Left ventricle auxiliary device

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant